Is the negative prognostic value of high oestrogen receptor (ER) levels in postmenopausal breast cancer patients due to a modified ER gene product?

Source:http://linkedlifedata.com/resource/pubmed/id/8541112

Download in:

View as

General Info

PMID
8541112